platinum has been researched along with Myeloproliferative Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abedin, S; Guru Murthy, GS | 1 |
1 review(s) available for platinum and Myeloproliferative Disorders
| Article | Year |
|---|---|
Myeloid malignancies after treatment for solid tumours.
Topics: Chemotherapy, Adjuvant; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Male; Myeloproliferative Disorders; Neoplasms, Second Primary; Platinum; Risk Factors; Topoisomerase II Inhibitors | 2019 |